SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending following a new multi-year joint research agreement with Honda, marking a significant validation of its solid-state battery technology by a major automotive OEM. While the community is actively debating the transition from research to mass manufacturing and monitoring for further potential OEM partnerships, investor sentiment remains focused on whether this technical progress will lead to commercial-scale production.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is trending following a record-breaking earnings report that highlighted significant revenue growth, a successful partnership with Midjourney, and the company's first positive operating cash flow. The community is actively debating the company's long-term potential as it transitions from a hardware-focused business to a semiconductor-driven AI platform.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors weigh recent financial disclosures, including a debt buyback and updated profitability timelines, against ongoing anticipation of EMA regulatory decisions. Community discourse remains divided between strong conviction in the companys long-term commercial potential and frustration over executive turnover and limited transparency from leadership.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Accenture is currently under intense pressure as investors express concerns that generative AI tools could disrupt the firm's traditional billable-hour consulting model. Community sentiment is notably bearish, with many questioning the company's long-term relevance and leadership strategy following a disappointing revenue outlook and significant stock price depreciation.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is seeing intense trading volume and volatility as the market reacts to shifting geopolitical tensions between the U.S. and Iran alongside broader uncertainty regarding Federal Reserve rate policy. Community discussions remain polarized, with many traders actively debating the sustainability of the ongoing AI-driven rally while utilizing the ETF to capitalize on rapid intraday price swings.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is trending as investors debate the sustainability of the current AI-driven market rally amid ongoing geopolitical instability and concerns over high tech valuations. Community discussion remains polarized, with many retail traders highlighting frustrations over market manipulation and the inherent risks of holding leveraged inverse products during an extended uptrend.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

The VanEck Gold Miners ETF (GDX) is trending as investors weigh conflicting macroeconomic signals, with the community actively debating whether the sector is experiencing a healthy consolidation or a failed breakdown amidst shifting expectations for Fed policy. Discussions remain focused on the impact of persistent inflation, the geopolitical landscape, and technical levels as traders attempt to gauge the next leg for gold miners.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending as the ETF breaks below its 200-day moving average, fueling investor anxiety over persistent inflation and potential Federal Reserve rate hikes. The community is actively debating whether this represents a structural breakdown in golds safe-haven status or an overextended correction providing a long-term accumulation opportunity.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is seeing intense community speculation and high volatility as investors anticipate the imminent 80th event milestone for the REGAL Phase 3 trial. Discussion is heavily focused on the stock's elevated short interest and rising borrow rates, with bulls positioning for a potential squeeze while highlighting the company's recent commentary on its transition toward late-stage commercialization.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust (SLV) is facing intense selling pressure as investors weigh cooling inflation expectations against ongoing geopolitical tensions in the Middle East and concerns over high interest rates. While some in the community argue that long-term industrial demand from AI infrastructure and solar manufacturing makes this a prime dip-buying opportunity, others remain skeptical, warning of further downside as the sector struggles to maintain its safe-haven status.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Senseonics Expands Eversense 365 Ecosystem With Welldoc Partnership

SENS partners with Welldoc on a next-gen Eversense 365 app, adding Apple Health/Google Health Connect integration ahead of the U.S. launch.

Senseonics Holdings (SENS) Reports Q1 Loss, Beats Revenue Estimates

Senseonics (SENS) delivered earnings and revenue surprises of -9.23% and +16.81%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) have received an average recommendation of "Moderate Buy" from the six research firms that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, one has issue...

Senseonics Shares Sink Friday: What's Driving The Move?

Shares of Senseonics Holdings Inc (NASDAQ:SENS) are tumbling Friday morning pricing an $80 million underwritten public offering late Thursday.read more...

The $5 Signal: Why Senseonics’ Capital Raise Is Dragging SENS Stock Down

Equity

Senseonics closed Thursday’s session at $6.61 per share, then announced the $5.00 stock offering after the bell.

The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms

The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms PR Newswire VANCOUVER, BC, April 29, 2026...

SENS Launches Eversense 365, World's Only One-Year CGM in Europe

Senseonics launches Eversense 365 in Europe, debuting the first year-long CGM system as it expands into key markets and targets millions of new patients.

Symmetry Partners LLC Reduces Stock Holdings in Senseonics Holdings, Inc. Common Stock $SENS

Symmetry Partners LLC reduced its stake in shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Free Report) by 95.0% during the fourth quarter, according to the company in its most recent...

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) have received an average rating of "Moderate Buy" from the seven research firms that are presently covering the firm...

MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value

MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value PR Newswire VANCOUVER, BC, March 27, 2026 Issued on behalf of...

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

SENSSenseonics Holdings Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SENS News